Avation Medical Announces Manish Vaishya, PhD as Chief Executive Officer; Closes Series D Financing
COLUMBUS, OH, UNITED STATES, March 20, 2026 / EINPresswire.com / --
Avation Medical, a global leader in treating bladder conditions with its innovative non-invasive neuromodulation technology, is pleased to announce a successful closing of Series D financing and is excited to appoint Manish Vaishya, PhD as Chief Executive Officer. Since co-founding Avation, Dr. Vaishya has led the company as Chief Technology Officer from inception of the Vivally System through multiple successful clinical trials, achieving ISO 13485 certification, FDA regulatory clearance of the Vivally System, ensuring commercial operational readiness, three rounds of funding and launch in the US market. He is a seasoned MedTech executive with over 25 years leading development and commercialization of innovative Class II and III medical devices and healthcare systems.
About Avation Medical
The Avation Medical team is driven by a mission to bring to market patient-friendly systems that make the promise of neuromodulation more accessible to patients and their physicians. Our leaders and team members have decades of success in medical technology, neuromodulation and digital health and are working hard to develop solutions that return quality of life to patients across a variety of clinical conditions.
Corporate Contact
Jackie Gerberry
Senior Director, Finance
Jgerberry@Avation.com
www.Avation.com